These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys. Delarue F; Hertig A; Alberti C; Vigneau C; Ammor M; Berrou J; Akposso K; Peraldi MN; Rondeau E; Sraer JD Transplantation; 2001 Oct; 72(7):1256-61. PubMed ID: 11602852 [TBL] [Abstract][Full Text] [Related]
5. An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies. Sreedharanunni S; Joshi K; Duggal R; Nada R; Minz M; Sakhuja V Transpl Int; 2014 Aug; 27(8):784-92. PubMed ID: 24684170 [TBL] [Abstract][Full Text] [Related]
6. Clinical-pathological correlations in post-transplant thrombotic microangiopathy. Broecker V; Bardsley V; Torpey N; Perera R; Montero R; Dorling A; Bentall A; Neil D; Willicombe M; Berry M; Roufosse C Histopathology; 2019 Jul; 75(1):88-103. PubMed ID: 30851188 [TBL] [Abstract][Full Text] [Related]
7. Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis. Hamano K; Iwano M; Akai Y; Sato H; Kubo A; Nishitani Y; Uyama H; Yoshida Y; Miyazaki M; Shiiki H; Kohno S; Dohi K Am J Kidney Dis; 2002 Apr; 39(4):695-705. PubMed ID: 11920334 [TBL] [Abstract][Full Text] [Related]
8. Clinical profile and outcomes of Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209 [TBL] [Abstract][Full Text] [Related]
9. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy. Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821 [TBL] [Abstract][Full Text] [Related]
10. [Kidney injury in transplantation-associated thrombotic microangiopathy]. Lu M; Zou WZ; Zhang Y; Wang SL; Wang W Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):392-4. PubMed ID: 18677386 [TBL] [Abstract][Full Text] [Related]
11. De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus. Cortina G; Trojer R; Waldegger S; Schneeberger S; Gut N; Hofer J Pediatr Nephrol; 2015 Apr; 30(4):693-7. PubMed ID: 25577332 [TBL] [Abstract][Full Text] [Related]
12. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Izzedine H; Mangier M; Ory V; Zhang SY; Sendeyo K; Bouachi K; Audard V; Péchoux C; Soria JC; Massard C; Bahleda R; Bourry E; Khayat D; Baumelou A; Lang P; Ollero M; Pawlak A; Sahali D Kidney Int; 2014 Feb; 85(2):457-70. PubMed ID: 24067439 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature. Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519 [TBL] [Abstract][Full Text] [Related]
14. A link between Krüppel-like factor 4, complement activation, and kidney damage. Karpman D; Loos S Kidney Int; 2022 Jul; 102(1):14-16. PubMed ID: 35738827 [TBL] [Abstract][Full Text] [Related]
15. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969 [TBL] [Abstract][Full Text] [Related]
17. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Schwarz A; Haller H; Schmitt R; Schiffer M; Koenecke C; Strassburg C; Lehner F; Gottlieb J; Bara C; Becker JU; Broecker V Am J Transplant; 2010 Sep; 10(9):2017-25. PubMed ID: 20883535 [TBL] [Abstract][Full Text] [Related]
18. Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy. Yamashita Y; Naitoh K; Wada H; Ikejiri M; Mastumoto T; Ohishi K; Hosaka Y; Nishikawa M; Katayama N Thromb Res; 2014 Mar; 133(3):440-4. PubMed ID: 24325877 [TBL] [Abstract][Full Text] [Related]
19. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival. Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601 [TBL] [Abstract][Full Text] [Related]
20. Preservation of peritoneal fibrinolysis owing to decreased transcription of plasminogen activator inhibitor-1 in peritoneal mesothelial cells suppresses postoperative adhesion formation in laparoscopic surgery. Shimomura M; Hinoi T; Ikeda S; Adachi T; Kawaguchi Y; Tokunaga M; Sasada T; Egi H; Tanabe K; Okajima M; Ohdan H Surgery; 2013 Mar; 153(3):344-56. PubMed ID: 23218127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]